None of the biology is new or contested. What is new is reading it as one continuous system, and refusing to overclaim what any single measurement can support.
None of the biology below is new or contested. That is the point. What's new is reading it as one continuous system rather than six disconnected snapshots, and refusing to overclaim what any single measurement can support. Open any pillar for the mechanism.
Stress responses protect you in the short term and cost you in the long term. Engaged repeatedly, they accumulate, and physiology gradually shifts. Capacity is therefore a balance of load against reserve, and cumulative drift matters more than any single bad week.
Neuroendocrine load theory · McEwen, NEJM 1998Stress mediators are adaptive in the moment and damaging when chronically engaged, producing measurable physiological change over time, which is the basis of allostatic load theory.
This is why the model is built as a balance rather than a score, and why it watches trajectory rather than snapshots. A person in the compensating state usually looks fine on any single day. The information is in the direction, not the reading.
Genital arousal depends on blood flow, and blood flow depends on the health of the vessel lining. That link runs both ways: new, unexplained erectile difficulty is a recognised early cardiovascular signal, not a bedroom footnote.
Vascular physiology of arousal · Princeton ConsensusNitric oxide produced by the endothelium is a principal mediator of genital blood flow; the vascular response is sustained by shear-stress-driven signalling, and reduced nitric-oxide availability is associated with arousal difficulty.
The clinical consequence is what matters to a reader: erectile dysfunction can precede clinically evident cardiovascular disease. New or unexplained ED, particularly in younger men or in diabetes, should trigger cardiovascular-risk assessment. It deserves a heart conversation, not just a prescription.
Attachment, partner preference and the felt sense of safety are supported by well-characterised neurochemistry. This is why "feeling safe with them" belongs in the model as a real term rather than a soft one.
Oxytocin signalling & pair-bonding literatureOxytocin signalling is a well-characterised modulator of pair-bonding, partner preference and social attachment. That grounds attachment safety as a measurable contributor rather than a sentiment.
And here is the line. No marker of this may be read as a verdict on trust, fidelity, attachment style, promiscuity or compatibility. The findings are not remotely deterministic enough for those uses, the temptation to use them that way is commercially obvious, and we refuse it explicitly.
Antidepressants, antipsychotics, opioids, hormonal and prostate treatments and several blood-pressure medicines all reshape desire, sensation and orgasm. People are rarely told this clearly, so they blame themselves instead.
Serotonergic & endocrine pharmacology literatureSerotonergic tone modulates orgasm and desire, which is why sexual side-effects are so common with serotonergic antidepressants. Other agents work through prolactin, androgen availability or sedation. Different mechanisms, different timelines, different answers.
Individual variation in how a person processes a given medicine can influence exposure and tolerability, which is context worth having when a conversation with a prescriber happens. It does not predict whether sexual difficulty will occur, and we present it as context rather than prophecy. The decision is always the clinician's.
Reproductive prime, pregnancy and postpartum, perimenopause, menopause, andropause and medicated states are physiologically distinct. One reference range across all of them manufactures problems and hides real ones.
Hormonal life-stage physiologyHormonal life stage strongly modulates capacity, so the model applies phase-aware expectations rather than uniform ranges. This lets phase-typical variation be distinguished from genuine drift.
It matters most where people are dismissed most. Genitourinary syndrome of menopause, which brings dryness, painful sex, urinary urgency and recurrent infections, is common, treatable and routinely written off as an inevitability of ageing. Postpartum discomfort, long-relationship responsive desire and medication-induced orgasm difficulty are three different things and must never receive the same explanation.
The body can respond without wanting. Wanting can arrive after touch begins rather than before, which is normal, not broken. A physical response never establishes consent, and orgasm never establishes enjoyment.
Sexual response & responsive desire researchGenital arousal, subjective arousal, desire, pleasure, consent, satisfaction and orgasm are separate phenomena that frequently move independently. Lubrication or erection does not establish consent. Orgasm can occur during an unwanted experience. Consensual activity can be unpleasant. A good experience needn't include orgasm at all.
Collapsing these is the source of an enormous amount of harm in clinics, in courtrooms and in bedrooms. Keeping them separate is the foundation of clinical accuracy and of trauma-informed care. And responsive desire is never an obligation to begin unwanted activity and wait for wanting to show up. Consent stays active and reversible throughout.
Biology can point to pathways: how hormones signal, how vessels respond, how stress is regulated, how pain is processed, how a medicine is handled. It cannot tell you who to love, whether you're compatible, whether you'll be faithful, what you should want, or who you are. Our findings describe conditions and possibilities. They never issue verdicts about a person or a relationship, and they never replace a clinician's judgement. We would rather tell you what we don't know than sell you certainty we don't have.
Join the waitlist for early access. We'll write only when something matters, and never about anything but this.